EU approves Roche's Actemra for severe COVID-19 - - Pharmaphorum

Retrieved on: 2021-12-07 10:58:25

Tags for this article:

Medical specialties

Drugs

COVID-19 drug development

Monoclonal antibodies

Tocilizumab

Casirivimab/imdevimab

Anti-IL-6

Treatment and management of COVID-19

Actemra

Click the tags to see associated articles and topics

EU approves Roche's Actemra for severe COVID-19 - - Pharmaphorum. View article details on HISWAI: https://pharmaphorum.com/news/eu-approves-roches-actemra-for-covid-19/

Excerpt

The European Commission has moved swiftly to approve Roche's Actemra as a COVID-19 treatment, acting within a day of the CHMP backing the IL-6 ...

Article found on: pharmaphorum.com

View Original Article